A study of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol in patients with seasonal allergic rhinitis from mountain cedar pollen

Allergy and Asthma Proceedings

Volumn 33, Issue 1, 2012, Pages 27-35

  Ratner, Paul H ^a   Andrews, Charles ^b   Martin, Bruce ^c   Howland, William ^d   Desai, Shailesh Y ^e   Huang, Holly ^e   Hinkle, Joseph ^e   Bode, Fred ^e  

^a Sylvana Research Associates   (United States)

^b Diagnostics Research Group   (United States)

^c Southwest Allergy and Asthma Center   (United States)

^d Sirius Clinical Research   (United States)

^e DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CICLESONIDE; FLUORINATED HYDROCARBON; PLACEBO;

AEROSOL; ALLERGY; ARTICLE; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; EAR INFECTION; FEMALE; HAY FEVER; HUMAN; JAPANESE CEDAR; MAJOR CLINICAL STUDY; MALE; MOUNTAINEERING; MULTICENTER STUDY; POLLEN; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; STREPTOCOCCAL PHARYNGITIS; TONSILLITIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ALLERGENS; ANTI-ALLERGIC AGENTS; ANTIGENS, PLANT; CEDRUS; FEMALE; HUMANS; HYDROCARBONS, FLUORINATED; MALE; MIDDLE AGED; NASAL SPRAYS; POLLEN; PREGNENEDIONES; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 84863120986     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3490     Document Type: Article

References (17)

1. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 28:3-9, 2007.
2. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: Findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 30:244-254, 2009.
3. Benninger MS, and Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc 30:358-365, 2009.
4. Storms WW. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol S146-S153, 2004. (Pubitemid 39440926)
5. Skoner DP. Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 108:S2-S8, 2001.
6. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122(Suppl 2):S1-S84, 2008. (Pubitemid 352033573)
7. Naclerio R. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg 138:129-139, 2008. (Pubitemid 351172486)
8. Mutch E, Nave R, McCracken N, et al. The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue. Biochem Pharmacol 73:1657-1664, 2007. (Pubitemid 46527549)
9. Ratner PH, Wingertzahn MA, van Bavel JH, et al. Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 118:1142-1148, 2006. (Pubitemid 44755181)
10. Meltzer EO, Kunjibettu S, Hall N, et al. Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol 98:175-181, 2007. (Pubitemid 46214225)
11. Sunovion Pharmaceuticals, Inc. Omnaris prescribing information. Marlborough, MA; 2010.
12. Ratner PH, Jacobs R, Mohar DE, et al. Evaluation of the efficacy and safety of ciclesonide HFA nasal aerosol 80 μg or 160 μg once daily for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 105:471-479, 2010.
13. World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. Helsinki, Finland, 1-7, 2008.
14. Dmitrienko A, Wiens BL, Tamhane AC, and Wang X. Treestructured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives. Stat Med 26:2465-2478, 2007. (Pubitemid 46784205)
15. Juniper EF, and Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21:77-83, 1991.
16. Juniper EF, Thompson AK, Ferrie PJ, and Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 104:364-369, 1999. (Pubitemid 29420434)
17. Waddell AN, Patel SK, Toma AG, and Maw AR. Intranasal steroid sprays in the treatment of rhinitis: Is one better than another? J Laryngol Otol 117:843-845, 2003. (Pubitemid 37468081)